Scandinavian ChemoTech
2,11
SEK
+1,93 %
Mindre end 1K følgere
CMOTEC B
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
+1,93%
+51,25%
+72,95%
+17,88%
+27,11%
-4,52%
-81,94%
-71,99%
-94,4%
Scandinavian ChemoTech is a research and development company that has developed the technology Tumor-Specific Electroporation - TSE ™ for the treatment of various cancers. The technology means that electronic pulses are sent to the treated area and the membranes of the tumor cells are opened to reach their DNA. In addition to its operations in Sweden, the company is also active in Southeast Asia and India. Scandinavian ChemoTech was founded in 2015 and is headquartered in Lund.
Læs mereMarkedsværdi
49,26 mio. SEK
Aktieomsætning
17,85 t SEK
Omsætning
6,57 mio.
EBIT %
-194,82 %
P/E
-
Udbytteafkast, %
-
Finanskalender
12.8
2025
Delårsrapport Q2'25
4.11
2025
Delårsrapport Q3'25
3.3
2026
Årsrapport '25
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Scandinavian ChemoTech AB (publ) publishes Interim Report Q1 2025
(RETRANS) ChemoTech's Animal Care Celebrates Record-Breaking Month with Order Intake of 200,000 USD
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools